MiMedx Group Inc (MDXG)
9.23
+0.01
(+0.11%)
USD |
NASDAQ |
Nov 22, 12:02
MiMedx Group Total Assets (Quarterly): 243.89M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 243.89M |
June 30, 2024 | 230.18M |
March 31, 2024 | 221.68M |
December 31, 2023 | 239.05M |
September 30, 2023 | 189.02M |
June 30, 2023 | 176.38M |
March 31, 2023 | 168.16M |
December 31, 2022 | 171.43M |
September 30, 2022 | 172.80M |
June 30, 2022 | 168.67M |
March 31, 2022 | 174.44M |
December 31, 2021 | 187.93M |
September 30, 2021 | 180.52M |
June 30, 2021 | 187.15M |
March 31, 2021 | 190.81M |
December 31, 2020 | 202.03M |
September 30, 2020 | 213.32M |
June 30, 2020 | 150.91M |
March 31, 2020 | 158.91M |
December 31, 2019 | 167.17M |
September 30, 2019 | 179.27M |
June 30, 2019 | 170.31M |
March 31, 2019 | 107.44M |
December 31, 2018 | 122.84M |
December 31, 2017 | 121.26M |
Date | Value |
---|---|
September 30, 2017 | 178.71M |
June 30, 2017 | 199.86M |
March 31, 2017 | 188.49M |
December 31, 2016 | 193.26M |
September 30, 2016 | 181.66M |
June 30, 2016 | 177.06M |
March 31, 2016 | 177.22M |
December 31, 2015 | 135.91M |
September 30, 2015 | 125.93M |
June 30, 2015 | 113.84M |
March 31, 2015 | 106.10M |
December 31, 2014 | 109.26M |
September 30, 2014 | 97.32M |
June 30, 2014 | 86.02M |
March 31, 2014 | 87.35M |
December 31, 2013 | 84.69M |
September 30, 2013 | 45.30M |
June 30, 2013 | 40.28M |
March 31, 2013 | 37.85M |
December 31, 2012 | 35.18M |
September 30, 2012 | 33.54M |
June 30, 2012 | 27.47M |
March 31, 2012 | 26.86M |
December 31, 2011 | 27.10M |
September 30, 2011 | 23.55M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
150.91M
Minimum
Jun 2020
243.89M
Maximum
Sep 2024
189.72M
Average
183.84M
Median
Total Assets (Quarterly) Benchmarks
CEL-SCI Corp | 24.07M |
AIM ImmunoTech Inc | 13.59M |
IGC Pharma Inc | 10.37M |
NovaBay Pharmaceuticals Inc | 3.877M |
Protalix BioTherapeutics Inc | 61.56M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 62.88M |
Shareholders Equity (Quarterly) | 181.01M |
Debt to Equity Ratio | 0.1051 |
Current Ratio | 4.104 |
Net Debt Paydown Yield | 0.69% |